Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark,
Cells Tissues Organs. 2020;209(4-6):257-265. doi: 10.1159/000513604. Epub 2021 Mar 22.
Adipose-derived stromal/stem cells (ASCs) are being tested as a possible treatment for a wide range of diseases to exploit the immunomodulatory and regenerative potential demonstrated in vitro. Pooled human platelet lysate (pHPL) has replaced fetal bovine serum (FBS) as the preferred growth supplement because of its xeno-free origin and improved cell proliferation. Much has been done toward reducing the concentration of pHPL required when expanding ASCs. However, little is known on how increasing the concentration of pHPL affects ASC potency, which could lead to changes with possible beneficial applications. This study investigated the effect of 5, 10, or 20% pHPL in culture media on ASC proliferation and phenotypic marker expression, including chemokine receptors CXCR2, CXCR3, CXCR4, and VLA-4. Adipogenic and osteogenic properties, as well as immunosuppressive properties, including the ability to induce indoleamine-pyrrole 2,3-dioxygenase 1 (IDO1) and suppress T cell proliferation, were also examined. We observed a significant increase in cell yield (approximately 2-fold) and a corresponding reduction in population doubling time and cell volume when doubling the concentration of pHPL in the growth media. ASCs maintained expression of phenotypic surface markers CD73, CD90, and CD105 and were negative for CD45 and CD31. The ability to induce IDO1 and suppress T cell proliferation was observed as well. Adipogenesis and osteogenesis, however, seem to be increased at higher concentrations of pHPL (20% > 10% > 5%), while expression of chemokine receptors CXCR2 and CXCR3 was lower. In conclusion, increasing the pHPL concentration to 20% could be used to optimize culture conditions when producing cells for clinical treatments and may even be used to enhance beneficial ASC properties depending on the desired therapeutic effect.
脂肪来源的基质/干细胞 (ASCs) 正在被测试作为治疗多种疾病的可能方法,以利用体外显示的免疫调节和再生潜力。由于其无动物来源和改善的细胞增殖作用,人血小板裂解液 (pHPL) 已取代胎牛血清 (FBS) 作为首选的生长补充剂。已经做了很多工作来降低扩增 ASC 时所需的 pHPL 浓度。然而,对于增加 pHPL 浓度如何影响 ASC 效力知之甚少,这可能会导致可能具有有益应用的变化。本研究调查了培养介质中 5%、10%或 20% pHPL 对 ASC 增殖和表型标志物表达的影响,包括趋化因子受体 CXCR2、CXCR3、CXCR4 和 VLA-4。还检查了成脂和成骨特性以及免疫抑制特性,包括诱导吲哚胺-吡咯 2,3-双加氧酶 1 (IDO1) 和抑制 T 细胞增殖的能力。我们观察到细胞产量显著增加(约 2 倍),并且当生长培养基中 pHPL 浓度加倍时,群体倍增时间和细胞体积相应减少。ASCs 保持表型表面标志物 CD73、CD90 和 CD105 的表达,并对 CD45 和 CD31 呈阴性。观察到诱导 IDO1 和抑制 T 细胞增殖的能力。然而,成脂和成骨似乎在更高浓度的 pHPL(20% > 10% > 5%)下增加,而趋化因子受体 CXCR2 和 CXCR3 的表达较低。总之,增加 pHPL 浓度至 20% 可用于优化用于临床治疗的细胞生产的培养条件,甚至可根据所需的治疗效果用于增强有益的 ASC 特性。